| |
| |
|
| Insider
Information: |
Taylor Stacy L |
| Relationship: |
SVP and General Counsel |
| City: |
Seattle |
| State: |
WA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
166,287 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$631,891 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
166,287 |
|
|
| Total
Value |
$631,891 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Adaptive Biotechnologies Corp |
ADPT |
SVP and General Counsel |
2024-03-05 |
166,287 |
2020-01-08 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ADPT |
Adaptive Biotechnologies ... |
SVP and General Counsel |
• – – |
2024-03-05 |
4 |
S |
$3.43 |
$45,963 |
D/D |
(13,381) |
166,287 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
SVP and General Counsel |
• – – |
2024-03-04 |
4 |
A |
$0.00 |
$0 |
D/D |
39,990 |
179,668 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
SVP and General Counsel |
• – – |
2023-03-07 |
4 |
AS |
$8.60 |
$115,128 |
D/D |
(13,387) |
139,678 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
SVP and General Counsel |
• – – |
2023-03-06 |
4 |
AS |
$8.57 |
$47,058 |
D/D |
(5,491) |
153,065 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
SVP and General Counsel |
• – – |
2023-03-06 |
4 |
A |
$0.00 |
$0 |
D/D |
85,697 |
158,556 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
SVP and General Counsel |
• – – |
2022-03-08 |
4 |
AS |
$11.44 |
$27,307 |
D/D |
(2,387) |
72,859 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
SVP and General Counsel |
• – – |
2022-03-07 |
4 |
S |
$12.01 |
$18,844 |
D/D |
(1,569) |
75,246 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
SVP and General Counsel |
• – – |
2022-03-04 |
4 |
A |
$0.00 |
$0 |
D/D |
61,779 |
76,815 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
SVP and General Counsel |
• – – |
2021-12-22 |
4 |
AS |
$30.00 |
$460,140 |
D/D |
(15,338) |
15,036 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
SVP and General Counsel |
• – – |
2021-12-22 |
4 |
OE |
$6.55 |
$106,974 |
D/D |
15,338 |
30,374 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
SVP and General Counsel |
• – – |
2021-09-07 |
4 |
AS |
$40.00 |
$19,800 |
D/D |
(495) |
15,036 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
SVP and General Counsel |
• – – |
2021-09-07 |
4 |
OE |
$6.55 |
$3,242 |
D/D |
495 |
15,531 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
SVP and General Counsel |
• – – |
2021-06-30 |
4 |
OE |
$6.55 |
$62,663 |
D/D |
4,167 |
19,203 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
SVP and General Counsel |
• – – |
2021-06-30 |
4 |
AS |
$41.35 |
$172,614 |
D/D |
(4,167) |
15,036 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
SVP and General Counsel |
• – – |
2021-06-17 |
4 |
AS |
$40.00 |
$166,640 |
D/D |
(4,166) |
15,036 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
SVP and General Counsel |
• – – |
2021-06-17 |
4 |
OE |
$6.55 |
$62,655 |
D/D |
4,166 |
19,202 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
SVP and General Counsel |
• – – |
2021-04-30 |
4 |
OE |
$6.55 |
$62,656 |
D/D |
4,166 |
19,202 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
SVP and General Counsel |
• – – |
2021-04-30 |
4 |
AS |
$41.93 |
$174,680 |
D/D |
(4,166) |
15,036 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
SVP and General Counsel |
• – – |
2021-03-31 |
4 |
AS |
$40.00 |
$166,680 |
D/D |
(4,167) |
15,036 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
SVP and General Counsel |
• – – |
2021-03-31 |
4 |
OE |
$6.55 |
$62,663 |
D/D |
4,167 |
19,203 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
SVP and General Counsel |
• – – |
2021-03-04 |
4 |
A |
$0.00 |
$0 |
D/D |
13,736 |
15,036 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
SVP and General Counsel |
• – – |
2021-02-26 |
4 |
AS |
$54.47 |
$156,138 |
D/D |
(2,812) |
1,300 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
SVP and General Counsel |
• – – |
2021-02-26 |
4 |
OE |
$6.55 |
$19,720 |
D/D |
2,812 |
4,112 |
0 |
- |
|
| ADPT |
Adaptive Biotechnologies ... |
SVP and General Counsel |
• – – |
2021-02-16 |
4 |
AS |
$63.43 |
$1,050,327 |
D/D |
(16,250) |
1,300 |
0 |
% |
|
| ADPT |
Adaptive Biotechnologies ... |
SVP and General Counsel |
• – – |
2021-02-16 |
4 |
OE |
$31.71 |
$515,288 |
D/D |
16,250 |
17,550 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
